Synbiotics decrease the incidence of septic complications in patients with severe SIRS: a preliminary report

Area of Science:

• Microbiology
• Gastroenterology
• Critical Care Medicine

Background:

• Severe systemic inflammatory response syndrome (SIRS) is associated with gut dysbiosis.
• Restoring gut microbiota balance is crucial for managing SIRS patients.

Purpose of the Study:

• To investigate the efficacy of synbiotics in correcting gut flora and environment in severe SIRS patients.
• To assess the impact of synbiotics on infectious complications in SIRS.

Main Methods:

• A cohort of 29 SIRS patients received synbiotics (Bifidobacterium breve, Lactobacillus casei, galactooligosaccharides).
• Fecal flora and organic acid levels were analyzed.
• Outcomes were compared to 26 SIRS patients who did not receive synbiotics.

Main Results:

• Synbiotic group showed significantly higher levels of beneficial Bifidobacterium, Lactobacillus, and total organic acids (including short-chain fatty acids).
• The incidence of infectious complications (enteritis, pneumonia, bacteremia) was significantly lower in the synbiotic group.
• Synbiotics helped maintain gut flora and environment.

Conclusions:

• Synbiotic therapy can restore gut microbiota balance and reduce septic complications in severe SIRS.
• Further randomized controlled trials are needed to confirm these findings.